Syncom Formulations (India) Ltd. (SYNCOMF): Syncom Formulations (India) Share Price rises 9.01% today

Published: 29 September 2026 at 10:52:43 AM IST

Syncom Formulations (India) Share Price moved higher today, with the stock at Rs 24.20 after a 9.01% rise from the previous close of Rs 22.20. The company’s market capitalisation stands at Rs 1,885.64 crore, placing the latest move in the context of a company that is already meaningfully valued within the healthcare space. The session opened at Rs 22.36, touched a high of Rs 24.85 and a low of Rs 22.06, while turnover stood at Rs 8.11 crore. This Syncom Formulations (India) Share Price update confirms a clear same-day gain, but the supplied data does not establish a company-specific catalyst. For readers following Syncom Formulations (India) Stock News or Syncom Formulations (India) Share Price Today, the key point is the magnitude of the day move and the company’s valuation backdrop. Univest is tracking the stock with a focus on verified price data, financial ratios and sector context.

Syncom Formulations (India) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 24.2
Previous Close	Rs 22.2
Today's Move	Rs 2 (+9.01%)
Open	Rs 22.36
High	Rs 24.85
Low	Rs 22.06
Turnover	Rs 8.11 crore
Market Capitalisation	Rs 1,885.64 crore
Market Cap Category	Small Cap

Syncom Formulations (India) Ltd. (SYNCOMF) rose to Rs 24.2 from the previous close of Rs 22.2, a move of Rs 2 or 9.01%. The stock opened at Rs 22.36, reached a high of Rs 24.85, recorded a low of Rs 22.06.

Syncom Formulations (India) Share Price rose Rs 2.00 on the day, closing at Rs 24.20 versus the previous close of Rs 22.20. The stock traded between Rs 22.06 and Rs 24.85 during the session, with the opening price at Rs 22.36. The day’s move places the counter among the notable gainers in the healthcare space today, and the current reading of Syncom Formulations (India) Share Price Today shows a stronger finish than the previous close. The latest Syncom Formulations (India) Stock News therefore centres on the verified price rise and the session range, rather than on any unconfirmed trigger. Turnover of Rs 8.11 crore provides a factual measure of traded value for the session.

Syncom Formulations (India) Ltd. (SYNCOMF) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,885.64 crore
P/E Ratio	24.4x
P/B Ratio	4.74x
ROE	20.19%
ROCE	26.8%
EPS	Rs 0.91
Book Value Per Share	Rs 4.68
Dividend Yield	0.45%

Syncom Formulations (India) Ltd. (SYNCOMF) fundamental metrics show P/E 24.4x, P/B 4.74x, ROE 20.19%, ROCE 26.8%. These figures provide context only and are not a buy or sell signal.

Syncom Formulations (India) Ltd. has a market capitalisation of Rs 1885.64 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 24.4x, P/B at 4.74x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.19% and ROCE of 26.8%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 0.91, book value per share of Rs 4.68, dividend yield of 0.45%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.59x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	24.4x
Benchmark Median P/E	32.59x
Benchmark Average P/E	49x
Benchmark P/E Range	3.46x to 707.31x
Company P/B Ratio	4.74x
Benchmark Median P/B	2.88x
Company ROE	20.19%
Benchmark Median ROE	11.7%
Company ROCE	26.8%
Benchmark Median ROCE	13.61%
Company Market Capitalisation	Rs 1,885.64 crore
Benchmark Median Market Cap	Rs 783.26 crore

Syncom Formulations (India) Ltd. (SYNCOMF) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Syncom Formulations (India) Ltd. (SYNCOMF) has a P/E ratio of 24.4x, which is below the benchmark median of 32.59x, a difference of -25.13%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Syncom Formulations (India) Ltd. (SYNCOMF) has a ROE of 20.19%, which is above the benchmark median of 11.7%, a difference of +72.56%. Syncom Formulations (India) Ltd. (SYNCOMF) has a ROCE of 26.8%, which is above the benchmark median of 13.61%, a difference of +96.91%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,44,716.74	36.5	5.1	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,55,115.31	86.51	14.33	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,89,613.38	84.92	20.64	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,19,899.96	26.79	4.48	19.69	21.39
Cipla Ltd.	CIPLA	1,12,875.68	33.29	3.19	11.83	16

Syncom Formulations (India) Ltd. (SYNCOMF) has a P/E ratio of 24.4x compared with the displayed peer median of 36.5x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.19% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 26.8% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Syncom Formulations (India) Ltd. (SYNCOMF) has a market capitalisation of Rs 1,885.64 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Syncom Formulations (India)

• The Syncom Formulations (India) Share Price rose 9.01% today to Rs 24.20.
• The session range was Rs 22.06 to Rs 24.85, with an opening price of Rs 22.36.
• Market capitalisation stands at Rs 1,885.64 crore, which frames the current Syncom Formulations (India) Stock News.
• ROE is 20.19% and ROCE is 26.8%, both above the sector median for the industry.
• P/E of 24.4 and P/B of 4.74 place the stock within a clear valuation comparison set in Healthcare.

About Syncom Formulations (India)

Syncom Formulations (India) is part of the Healthcare sector and operates in Pharmaceuticals & Drugs. The company’s share price update is being discussed in the context of a listed pharmaceutical business whose market capitalisation, valuation ratios and profitability metrics are now available for comparison on Univest. Based on the supplied data, the stock belongs to an industry where valuations and return ratios vary widely across peers, and that makes company-specific fundamentals important for reading the day’s move. The latest Syncom Formulations (India) Share News therefore sits at the intersection of price action, profitability and industry benchmarking. Readers tracking Syncom Formulations (India) Latest News can use this context to understand the stock’s position within the broader healthcare market.

Track Syncom Formulations (India) Share Price on Univest

Use Syncom Formulations (India) Ltd. (SYNCOMF) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Frequently Asked Questions

Why did Syncom Formulations (India) Share Price rise today?

Ans. The supplied data confirms a 9.01% rise in Syncom Formulations (India) Share Price to Rs 24.20, but it does not establish a company-specific catalyst. The article therefore focuses on verified price action, turnover and valuation context.

What is Syncom Formulations (India) Share Price today?

Ans. Syncom Formulations (India) Share Price today is Rs 24.20, compared with the previous close of Rs 22.20. The stock added Rs 2.00 during the session and moved within a range of Rs 22.06 to Rs 24.85.

How much did Syncom Formulations (India) share price gain today?

Ans. Syncom Formulations (India) share price gained 9.01% today. That move came with a Rs 2.00 increase from the previous close, and the stock finished the day at Rs 24.20. The previous close was Rs 22.2.

What is the market capitalisation of Syncom Formulations (India)?

Ans. Syncom Formulations (India) has a market capitalisation of Rs 1,885.64 crore. This places the company above the sector median market cap in the same industry benchmark, though below the larger listed pharmaceutical names.

How does Syncom Formulations (India) look on valuation?

Ans. Syncom Formulations (India) has a P/E ratio of 24.4 and a P/B ratio of 4.74. Its P/E is below the same-industry median, while its P/B is above the median and close to the sector average.

What do Syncom Formulations (India) ROE and ROCE show?

Ans. ROE is 20.19% and ROCE is 26.8% for Syncom Formulations (India). Both are above the same-industry median and average, which gives useful profitability context alongside the day’s share price rise.

How does Syncom Formulations (India) compare with peers?

Its ROCE is higher than most shown peers.

Can investors track Syncom Formulations (India) Share Price on Univest?

Ans. Yes. Univest tracks Syncom Formulations (India) Share Price with live updates, valuation ratios, company fundamentals, sector comparisons and market-cap context. Readers can use it to follow the stock’s verified movements and financial profile.